THE FREQUENCY OF HLA-B*57:01 AND THE RISK OF ABACAVIR HYPERSENSITIVITY REACTIONS IN THE COSTA RICA CENTRAL VALLEY POPULATION

被引：0
|
作者：
Arrieta-Bolanos, Esteban [1 ,2 ]
Madrigal, J. Alejandro [3 ,4 ]
Shaw, Bronwen E. [3 ,4 ,5 ]
Marsh, Steven G. E. [3 ,4 ]
Salazar-Sanchez, Lizbeth [2 ]
机构：
[1] Univ Costa Rica, Anthony Nolan Res Inst, UCL Canc Inst, San Jose, Costa Rica
[2] Univ Costa Rica, Ctr Invest Hematol & Trastornos Afines CIHATA, San Jose, Costa Rica
[3] UCL Canc Inst, London, England
[4] Anthony Nolan Res Inst, London, England
[5] Inst Canc Res, Div Mol Pathol, Haematooncol Res Unit, London SW3 6JB, England
来源：
TISSUE ANTIGENS | 2012年 / 79卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：525 / 525
页数：1
相关论文
共 50 条
  • [31] External quality assessment of patient HLA-B*57:01 testing prior to abacavir prescription
    Darke, C.
    Corbin, S. A.
    INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2014, 41 (04) : 277 - 280
  • [32] Abacavir competes for HLA-B*57:01 restricted peptide presentation in HLA-transgenic mice.
    Tilahun, Mulualem E.
    Natarajan, Kannan
    Boyd, Lisa F.
    Cardone, Marco
    Norcross, Michael A.
    Margulies, David H.
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [33] Diagnostic accuracy of HLA-B*57:01 screening for the prediction of abacavir hypersensitivity and clinical utility of the test: a meta-analytic review
    Cargnin, Sarah
    Jommi, Claudio
    Canonico, Pier Luigi
    Genazzani, Armando A.
    Terrazzino, Salvatore
    PHARMACOGENOMICS, 2014, 15 (07) : 963 - 976
  • [34] The Convenience of Flow Cytometry for HLA-B*5701 Screening to Prevent Abacavir Hypersensitivity Reactions
    Airo, Paolo
    Scarsi, Mirko
    Malagoli, Alberto
    Carella, Graziella
    Izzo, Ilaria
    Carosi, Giampiero
    Torti, Carlo
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 51 (03) : 361 - 362
  • [35] HLA-B*57:01 ALLELE RESEARCH IN HIV PATIENTS FOR ABACAVIR TREATMENT: A SINGLE CENTER EXPERIENCE
    Cappuzzo, Valentina
    Ingrassia, Francesco
    Blando, Maria
    Vega, Igea
    Bavetta, Rosalba
    Collura, Emanuela
    Mistretta, Serena
    Marceno, Raimondo
    TISSUE ANTIGENS, 2014, 84 (01): : 155 - 156
  • [36] A transgenic mouse model for HLA-B*57: 01-linked abacavir drug tolerance and reactivity
    Cardone, Marco
    Garcia, Karla
    Tilahun, Mulualem E.
    Boyd, Lisa F.
    Gebreyohannes, Sintayehu
    Yano, Masahide
    Roderiquez, Gregory
    Akue, Adovi D.
    Juengst, Leslie
    Mattson, Elliot
    Ananthula, Suryatheja
    Natarajan, Kannan
    Puig, Montserrat
    Margulies, David H.
    Norcross, Michael A.
    JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (07): : 2819 - 2832
  • [37] The Prevalence of HLA-B*57 Serotype Associated with Hypersensitivity Reactions in the Treatment of HIV İnfection in the Turkish Population
    Kizmaz, Muhammed Ali
    Simsek, Abdurrahman
    Aymak, Figen
    Akalin, Emin Halis
    Oral, Haluk Barbaros
    Budak, Ferah
    CURRENT HIV RESEARCH, 2023, 21 (04) : 254 - 258
  • [38] Unravelling the Proteomics of HLA-B*57:01+ Antigen Presenting Cells during Abacavir Medication
    Haukamp, Funmilola Josephine
    Gall, Eline
    Ho, Gia-Gia Toni
    Hiemisch, Wiebke
    Stieglitz, Florian
    Kuhn, Joachim
    Blasczyk, Rainer
    Pich, Andreas
    Bade-Doeding, Christina
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (01):
  • [39] Tag SNPs of the ancestral haplotype 57.1 do not substitute HLA-B*57:01 typing for eligibility to abacavir treatment in the Italian population
    Badulli, Carla
    Sestini, Roberta
    Sbarsi, Ilaria
    Baroncelli, Marta
    Pizzochero, Cinzia
    Martinetti, Miryam
    Porfirio, Berardino
    PHARMACOGENOMICS, 2012, 13 (03) : 247 - 249
  • [40] Novel sensitive, specific and rapid pharmacogenomic test for the prediction of abacavir hypersensitivity reaction: HLA-B*57:01 detection by real-time PCR
    Dello Russo, Cinzia
    Lisi, Lucia
    Lofaro, Alessia
    Di Giambenedetto, Simona
    Federico, Bruno
    madeddu, Giordano
    Salerno, Marianna
    Mura, Maria Stella
    Pirazzoli, Antonella
    de Luca, Andrea
    Cauda, Roberto
    Navarra, Pierluigi
    PHARMACOGENOMICS, 2011, 12 (04) : 567 - 576
12345